A Study of the Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With Asparaginase
Clinical trial NCT02369653 · COMPLETED
Trial details
- NCT number
- NCT02369653
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-22
- Primary completion
- 2021-07-07
- Enrollment
- 512
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.